These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7643728)

  • 21. What is the schizophrenic patients' level of information about their disease and their treatment?
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000 Oct; 26 Spec No 1():15-22. PubMed ID: 11294058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of characteristics between geriatric and younger subjects with schizophrenia in community.
    Ran MS; Xiang MZ; Conwell Y; Lamberti JS; Huang MS; Shan YH; Hu XZ
    J Psychiatr Res; 2004; 38(4):417-24. PubMed ID: 15203294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
    Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
    J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The perceived burden among Chinese family caregivers of people with schizophrenia.
    Chien WT; Chan SW; Morrissey J
    J Clin Nurs; 2007 Jun; 16(6):1151-61. PubMed ID: 17518890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic reassessment and treatment response in schizophrenia.
    Honer WG; Smith GN; MacEwan GW; Kopala L; Altman S; Yorkston N; Ehmann TS; Smith A; Lang M
    J Clin Psychiatry; 1994 Dec; 55(12):528-32. PubMed ID: 7814346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychopathology and outcome in first-admission schizophrenia: a 13-year follow-up study at a medical school hospital].
    Kobayashi T
    Seishin Shinkeigaku Zasshi; 2001; 103(5):383-410. PubMed ID: 11510079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of untreated illness (DUI) and schizophrenia sub-types: a collaborative study between the universities of Milan and Moscow.
    Buoli M; Dell'osso B; Zaytseva Y; Gurovich IY; Movina L; Dorodnova A; Shmuckler A; Altamura AC
    Int J Soc Psychiatry; 2013 Dec; 59(8):765-70. PubMed ID: 23034286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres.
    Wiersma D; Wanderling J; Dragomirecka E; Ganev K; Harrison G; An Der Heiden W; Nienhuis FJ; Walsh D
    Psychol Med; 2000 Sep; 30(5):1155-67. PubMed ID: 12027051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years.
    Schmidt M; Blanz B; Dippe A; Koppe T; Lay B
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(2):93-100. PubMed ID: 7654793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving reliability of the assessment of the life course of schizophrenia.
    Thompson AH; Newman SC; Orn H; Bland RC
    Can J Psychiatry; 2010 Nov; 55(11):729-35. PubMed ID: 21070701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family burden in relatives of schizophrenics and of people with mental retardation: A comparative study.
    Pariante C; Carpiniello B
    Eur Psychiatry; 1996; 11(8):381-5. PubMed ID: 19698486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Level of aspiration and social desirability in chronic schizophrenics.
    NORMAN RP
    J Consult Psychol; 1963 Feb; 27():40-4. PubMed ID: 13938945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical course and social outcome in schizophrenia. Results from a retrospective study].
    Carpiniello B; Salis P; Pariante CM; Carta MG; Rudas N
    Minerva Psichiatr; 1995 Mar; 36(1):1-10. PubMed ID: 7643728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective evaluation of the early course of schizophrenia in men and women after a first psychiatric hospitalization].
    Jaracz K; Górna K; Kiejda J; Rybakowski J
    Psychiatr Pol; 2008; 42(1):33-46. PubMed ID: 18567402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.